Medication Access Is Becoming an Enterprise Workflow Layer

Automation is moving medication access from a narrow admin task into a core enterprise layer that determines whether prescriptions become filled therapies.

Updated

What is this trend?

Medication access is shifting from a back-office prior authorization task into an enterprise workflow layer that automates the path from prescription to dispensed therapy.

  • Automation now spans prior auth, appeals, financial aid, and pharmacy routing.
  • The value is in converting written prescriptions into filled prescriptions at scale.
  • Specialty-specific integrations are becoming a key competitive moat.
  • Medication access is emerging as infrastructure, not a point solution.
  • Enterprise buyers want workflow tools tied to revenue realization and patient conversion.

What’s the latest?

Forus raised a $150 million Series C led by Bain Capital Ventures at a $3 billion valuation, reportedly tripling its value in about four months and lifting total funding above $300 million.

How it developed

  1. Workflow-Embedded AI Execution, Operational Interoperability, Platform M&A, and Outcome-Backed Hybrid Care
    • Outcome-Backed Hybrid Care Is Winning Capital

Go deeper

Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.

Related trends

Stay ahead in HealthTech

Get the weekly brief in your inbox — the developments, what they mean by vantage, and what to do next.